GlaxoSmithKline Current Ratio 2006-2018 | GSK

Current and historical current ratio for GlaxoSmithKline (GSK) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. GlaxoSmithKline current ratio for the three months ending September 30, 2018 was 0.95.
GlaxoSmithKline Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $22.70B $23.97B 0.95
2018-06-30 $23.20B $24.77B 0.94
2018-03-31 $22.85B $37.47B 0.61
2017-12-31 $20.50B $34.24B 0.60
2017-09-30 $23.12B $35.92B 0.64
2017-06-30 $21.01B $36.81B 0.57
2017-03-31 $20.79B $23.23B 0.90
2016-12-31 $22.65B $25.75B 0.88
2016-09-30 $23.13B $23.82B 0.97
2016-06-30 $24.22B $25.98B 0.93
2016-03-31 $22.68B $19.94B 1.14
2015-12-31 $25.36B $20.52B 1.24
2015-09-30 $26.33B $19.77B 1.33
2015-06-30 $27.75B $21.13B 1.31
2015-03-31 $31.63B $23.93B 1.32
2014-12-31 $24.19B $21.91B 1.10
2014-09-30 $24.83B $25.52B 0.97
2014-06-30 $22.81B $20.62B 1.11
2014-03-31 $21.92B $19.31B 1.14
2013-12-31 $23.83B $21.40B 1.11
2013-09-30 $20.88B $19.89B 1.05
2013-06-30 $20.64B $19.17B 1.08
2013-03-31 $21.93B $18.66B 1.18
2012-12-31 $21.70B $21.90B 0.99
2012-09-30 $21.32B $22.06B 0.97
2012-06-30 $27.34B $24.39B 1.12
2012-03-31 $25.57B $22.83B 1.12
2011-12-31 $25.94B $24.08B 1.08
2011-09-30 $26.43B $21.13B 1.25
2011-06-30 $26.62B $22.23B 1.20
2011-03-31 $26.90B $20.99B 1.28
2010-12-31 $24.80B $19.51B 1.27
2010-09-30 $26.03B $17.42B 1.49
2010-06-30 $25.48B $17.91B 1.42
2010-03-31 $28.66B $18.98B 1.51
2009-12-31 $27.51B $18.98B 1.45
2009-09-30 $28.47B $18.26B 1.56
2009-06-30 $23.61B $13.99B 1.69
2009-03-31 $24.40B $14.02B 1.74
2008-12-31 $32.03B $18.58B 1.72
2008-09-30 $28.37B $16.69B 1.70
2008-06-30 $28.95B $16.30B 1.78
2008-03-31 $24.94B $18.47B 1.35
2007-12-31 $27.27B $20.70B 1.32
2007-09-30 $23.00B $18.25B 1.26
2007-06-30 $21.78B $14.31B 1.52
2007-03-31 $14.22B $9.75B 1.46
2006-12-31 $20.26B $13.39B 1.51
2006-09-30 $22.30B $13.67B 1.63
2006-06-30 $23.12B $15.07B 1.53
2006-03-31 $24.44B $16.38B 1.49
2005-12-31 $24.00B $17.32B 1.39
2005-09-30 $23.86B $15.96B 1.50
2005-06-30 $22.79B $15.66B 1.46
2005-03-31 $21.51B $17.76B 1.21
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $100.041B $38.892B
GlaxoSmithKline is one of the world's leading research based pharmaceutical and healthcare companies and is committed to improving the quality of human life by enabling people to do more, feel better and live longer. They also have leadership in four major therapeutic areas: anti-infectives, central nervous system (CNS), respiratory and gastro-intestinal/metabolic.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $391.677B 18.36
Pfizer (PFE) United States $259.009B 14.60
Merck (MRK) United States $205.072B 17.77
Novartis AG (NVS) Switzerland $203.357B 17.38
AbbVie (ABBV) United States $137.681B 12.22
Eli Lilly (LLY) United States $120.583B 21.20
Sanofi (SNY) France $113.115B 14.01
Novo Nordisk (NVO) Denmark $107.931B 17.53
AstraZeneca (AZN) United Kingdom $103.013B 12.79
Bristol-Myers Squibb (BMY) United States $88.253B 14.53